Integrated transcriptomic and immunogenomic analysis unravels the immunological functions and prognostic landscape of WD repeat domain 76
Pan-cancer analysis establishes WDR76 as a robust pan-cancer prognostic biomarker and a potential immunotherapeutic target and provides experimental evidence that WDR76 functions as an oncogenic driver in liver cancer, promoting malignant phenotypes and offering a novel avenue for targeted therapeutic intervention.